Supplemental Figure 9. Real-Time killing assay of CAR.GD2 T-cells vs DAOY-GFP cell line pre-treated with Tazemetostat.
No takes yet. Share an insight, caveat, or question.
Ciccone et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: